GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Medclair AB (NGM:MCLR) » Definitions » Return-on-Tangible-Equity

Medclair AB (NGM:MCLR) Return-on-Tangible-Equity : 89.39% (As of Mar. 2025)


View and export this data going back to 2017. Start your Free Trial

What is Medclair AB Return-on-Tangible-Equity?

Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Medclair AB's annualized net income for the quarter that ended in Mar. 2025 was kr15.80 Mil. Medclair AB's average shareholder tangible equity for the quarter that ended in Mar. 2025 was kr17.68 Mil. Therefore, Medclair AB's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2025 was 89.39%.

The historical rank and industry rank for Medclair AB's Return-on-Tangible-Equity or its related term are showing as below:

NGM:MCLR' s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: -257.37   Med: -62.51   Max: 32.46
Current: 32.46

During the past 10 years, Medclair AB's highest Return-on-Tangible-Equity was 32.46%. The lowest was -257.37%. And the median was -62.51%.

NGM:MCLR's Return-on-Tangible-Equity is ranked better than
89.84% of 758 companies
in the Medical Devices & Instruments industry
Industry Median: 2.585 vs NGM:MCLR: 32.46

Medclair AB Return-on-Tangible-Equity Historical Data

The historical data trend for Medclair AB's Return-on-Tangible-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medclair AB Return-on-Tangible-Equity Chart

Medclair AB Annual Data
Trend Apr15 Apr16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Return-on-Tangible-Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only - -127.00 -26.94 -17.94 -4.38

Medclair AB Quarterly Data
Dec19 Jun20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Return-on-Tangible-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -4.86 92.93 -60.22 13.85 89.39

Competitive Comparison of Medclair AB's Return-on-Tangible-Equity

For the Medical Devices subindustry, Medclair AB's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medclair AB's Return-on-Tangible-Equity Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Medclair AB's Return-on-Tangible-Equity distribution charts can be found below:

* The bar in red indicates where Medclair AB's Return-on-Tangible-Equity falls into.


;
;

Medclair AB Return-on-Tangible-Equity Calculation

Medclair AB's annualized Return-on-Tangible-Equity for the fiscal year that ended in Dec. 2024 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(A: Dec. 2024 )  (A: Dec. 2023 )(A: Dec. 2024 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets )/ count )
(A: Dec. 2024 )  (A: Dec. 2023 )(A: Dec. 2024 )
=-0.664/( (14.392+15.93 )/ 2 )
=-0.664/15.161
=-4.38 %

Medclair AB's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2025 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(Q: Mar. 2025 )  (Q: Dec. 2024 )(Q: Mar. 2025 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets)/ count )
(Q: Mar. 2025 )  (Q: Dec. 2024 )(Q: Mar. 2025 )
=15.804/( (15.93+19.431)/ 2 )
=15.804/17.6805
=89.39 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Mar. 2025) net income data. Return-on-Tangible-Equity is displayed in the 10-year financial page.


Medclair AB  (NGM:MCLR) Return-on-Tangible-Equity Explanation

Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.


Be Aware

Net Income is used.

Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.


Medclair AB Return-on-Tangible-Equity Related Terms

Thank you for viewing the detailed overview of Medclair AB's Return-on-Tangible-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Medclair AB Business Description

Traded in Other Exchanges
N/A
Address
Box 3113, Stockholm, SWE, 103 62
Medclair AB operates in healthcare industry. The company has two units: Central Destruction Unit (CDU) and Mobile Destruction Unit (MDU) decomposes up to 99% of the nitrous oxide entering the unit, transforming it to nitrogen (N2) och oxygen (O2). It also provide solutions for various N2O methods such as double mask, single mask, mouthpiece, or free flow, which ensures a safe work environment for healthcare professionals.

Medclair AB Headlines

No Headlines